GPCR - Company ID 0001888886
The table below shows Structure Therapeutics Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $15.23M | -$52.23M | -$34.08M | -$20.31M | -$13.52M |
| Capital expenditure | $1.18M | $314.00K | $162.00K | - | $65.00K |
| Investing cash flow | -$496.95M | $34.03M | $1.42M | -$49.02M | -$39.72M |
| Dividends paid | - | - | - | - | - |
| Stock buybacks | - | - |
Structure Therapeutics Inc. reported operating cash flow of -$222.20M for fiscal year 2025. That is down 90.5% from -$116.64M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Financing cash flow | -$1.74M | $809.00K | $702.00K | $169.73M | -$1.45M |